Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Investing and increasing
May 2020
SHARING OPTIONS:

NEEDHAM, Mass.—Thermo Fisher Scientific is gearing up for a year of growth, having announced the planned investment of more than $475 million to boost its capabilities and capacity this year. Specifically, the company is looking to strengthen its abilities in biologics; cell and gene therapy; and drug product development and commercial capabilities. Thermo Fisher recently completed a $50-million expansion of its St. Louis site that has doubled its production capacity, and intends to open a Bioprocessing Collaboration Center at that site in July. The company has also expanded its viral vector development and manufacturing capabilities, having established a new site in Lexington, Mass.; expanding sites in Cambridge, Mass. and Alachua, Fla.; and planning the opening of a new cell therapy development and manufacturing collaboration center in Princeton, N.J.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.